🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

96+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 16 of 96 recruiting trials for “cystic-fibrosis

RecruitingNCT04469439

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

👨‍⚕️ Daniel M Beswick, MD, University of California, Los Angeles📍 9 sites📅 Started Jul 2020View details ↗
RecruitingNCT04002882

Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)

👨‍⚕️ Jessica A Alvarez, PhD, RD, Emory University📍 2 sites📅 Started Jul 2019View details ↗
NARecruitingNCT03655249

Effects of AD on VI in Patients With CF

👨‍⚕️ Gregory Reychler, PT, PhD, Cliniques universitaires Saint-Luc- Université Catholique de Louvain📍 1 site📅 Started Aug 2018View details ↗
NARecruitingNCT04732910

Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators

👨‍⚕️ Marcus A Mall, MD, Charite University, Berlin, Germany📍 4 sites📅 Started Jul 2018View details ↗
NARecruitingNCT03839992

Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis

👨‍⚕️ Arthur Gelb, MD, University of California, Los Angeles📍 2 sites📅 Started Apr 2018View details ↗
RecruitingNCT03161808

Rare CFTR Mutation Cell Collection Protocol (RARE)

🏥 George Solomon📍 1 site📅 Started Oct 2017View details ↗
RecruitingNCT03052283

Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score)

👨‍⚕️ Jochen G Mainz, Prof. MD, Medizinische Hochschule Brandenburg (MHB), University📍 2 sites📅 Started Jan 2017View details ↗
NARecruitingNCT02965326

Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients

👨‍⚕️ Aleksander Edelman, phD, APHP📍 1 site📅 Started May 2016View details ↗
RecruitingNCT03670472

Correction of Nonsense Mutations in Cystic Fibrosis

👨‍⚕️ Anne Prévotat, MD, University Hospital, Lille📍 8 sites📅 Started Feb 2016View details ↗
Phase 2RecruitingNCT02740868

Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

👨‍⚕️ Giles Santyr, PhD, The Hospital for Sick Children📍 1 site📅 Started Aug 2015View details ↗
NARecruitingNCT02417740

Natural History of Noncirrhotic Portal Hypertension

👨‍⚕️ Theo Heller, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)📍 1 site📅 Started Jul 2015View details ↗
RecruitingNCT01852448

Genetics of Insulin and Incretins in Cystic Fibrosis

👨‍⚕️ Andrea Kelly, MD, Children's Hospital of Philadelphia📍 2 sites📅 Started May 2013View details ↗
NARecruitingNCT01851694

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

👨‍⚕️ Michael R. Rickels, MD, MS, University of Pennsylvania📍 1 site📅 Started May 2013View details ↗
RecruitingNCT00943514

Natural History of Bronchiectasis

👨‍⚕️ Kevin P Fennelly, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Aug 2009View details ↗
NARecruitingNCT00001532

Role of Genetic Factors in the Development of Lung Disease

👨‍⚕️ Joel Moss, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 2 sites📅 Started Sep 1996View details ↗
RecruitingNCT00001205

Natural History of Treated Neurocysticercosis and Long-Term Outcomes

👨‍⚕️ Elise M O'Connell, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Oct 1985View details ↗
← PreviousPage 5 of 5

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →